US nod for Gilead’s pan-genotypic hep C pill
admin 19th July 2017 Uncategorised 0The US Food and Drug Administration has waved through Gilead’s new hepatitis C therapy Vosevi, offering adults with all genotypes of the condition a new treatment option in the form of three medicines in a single pill.
More: US nod for Gilead’s pan-genotypic hep C pill
Source: News